A detailed history of Robbins Farley LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Robbins Farley LLC holds 160 shares of JNJ stock, worth $24,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
160
Previous 150 6.67%
Holding current value
$24,880
Previous $21,000 19.05%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $1,454 - $1,673
10 Added 6.67%
160 $25,000
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $7,280 - $7,944
-50 Reduced 25.0%
150 $23,000
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $7,100 - $7,641
-46 Reduced 18.7%
200 $33,000
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $7,369 - $8,270
46 Added 23.0%
246 $43,000
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $7,973 - $8,553
50 Added 33.33%
200 $33,000
Q4 2020

Mar 04, 2021

BUY
$137.11 - $157.38 $20,566 - $23,607
150 New
150 $24,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Robbins Farley LLC Portfolio

Follow Robbins Farley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robbins Farley LLC with notifications on news.